New dissolving stent aims to prevent repeat tear duct surgery
NCT ID NCT07499791
First seen Apr 05, 2026 · Last updated May 20, 2026 · Updated 9 times
Summary
This study tests a special stent placed during tear duct surgery to prevent scarring and infection return. The stent slowly releases medicine and dissolves over time. About 40 adults with recurrent chronic dacryocystitis will be randomly assigned to get the new stent or standard packing. The goal is to see if the stent improves surgical success and reduces the need for further treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC DACRYOCYSTITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Beijing Tongren Hospital, Capital Medical University, Beijing, Beijing 100000
Beijing, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.